Assertio Holdings Inc

詳細情報 Assertio Holdings Inc 企業名

Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).

Assertio Holdings Incの企業情報



企業コードASRT

会社名Assertio Holdings Inc

上場日Feb 12, 1997

最高経営責任者「CEO」Mr. Brendan P. O'Grady

従業員数58

証券種類Ordinary Share

決算期末Feb 12

本社所在地100 S. Saunders Road

都市LAKE FOREST

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号60045

電話番号12244197106

ウェブサイトhttps://www.assertiotx.com/

企業コードASRT

上場日Feb 12, 1997

最高経営責任者「CEO」Mr. Brendan P. O'Grady

Assertio Holdings Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Ajay Patel

Chief Financial Officer, Executive Vice President

196.85K

+12.05%

Mr. Paul Schwichtenberg

Executive Vice President, Chief Transformation Officer

167.52K

+14.47%

Mr. Sam Schlessinger

Executive Vice President, General Counsel

156.13K

+17.33%

Mr. David Matthew Stark

Independent Director

107.50K

+100.00%

Mr. William T. Mckee

Independent Director

97.28K

+123.48%

Mr. Mark L. Reisenauer

Chief Executive Officer, Director

53.75K

--

Ms. Heather L. Mason

Independent Chairman of the Board

--

Mr. Sigurd C. (Sig) Kirk

Independent Director

--

Mr. Sravan K. Emany

Independent Director

--

Ms. Mary E Pietryga

Executive Vice President, Chief Commercial Officer

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Ajay Patel

Chief Financial Officer, Executive Vice President

196.85K

+12.05%

Mr. Paul Schwichtenberg

Executive Vice President, Chief Transformation Officer

167.52K

+14.47%

Mr. Sam Schlessinger

Executive Vice President, General Counsel

156.13K

+17.33%

Mr. David Matthew Stark

Independent Director

107.50K

+100.00%

Mr. William T. Mckee

Independent Director

97.28K

+123.48%

Mr. Mark L. Reisenauer

Chief Executive Officer, Director

53.75K

--

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

ROLVEDON

16.13M

55.19%

other

4.44M

15.20%

Sympazan

3.24M

11.10%

INDOCIN products

3.03M

10.38%

SPRIX Nasal Spray

1.98M

6.76%

Royalties and milestone revenue

400.00K

1.37%

地域別USD

会社名

収益

比率

United States

29.22M

100.00%

事業別

地域別

事業別USD

会社名

収益

比率

ROLVEDON

16.13M

55.19%

other

4.44M

15.20%

Sympazan

3.24M

11.10%

INDOCIN products

3.03M

10.38%

SPRIX Nasal Spray

1.98M

6.76%

Royalties and milestone revenue

400.00K

1.37%

株主

更新時刻: Sun, Aug 17

株主統計

種類

株主統計

比率

Nantahala Capital Management, LLC

9.15%

The Vanguard Group, Inc.

4.56%

Renaissance Technologies LLC

2.93%

BlackRock Institutional Trust Company, N.A.

1.43%

Geode Capital Management, L.L.C.

1.06%

他の

80.87%

株主統計

比率

Nantahala Capital Management, LLC

9.15%

The Vanguard Group, Inc.

4.56%

Renaissance Technologies LLC

2.93%

BlackRock Institutional Trust Company, N.A.

1.43%

Geode Capital Management, L.L.C.

1.06%

他の

80.87%

種類

株主統計

比率

Hedge Fund

14.08%

Investment Advisor

9.33%

Investment Advisor/Hedge Fund

3.41%

Individual Investor

2.61%

Research Firm

0.05%

Venture Capital

0.01%

他の

70.51%

機関投資家保有株



更新時刻: Wed, Oct 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q3

269

25.82M

26.82%

-22.80M

2025Q2

311

28.52M

29.77%

-30.86M

2025Q1

337

28.16M

29.40%

-32.55M

2024Q4

339

31.00M

32.47%

-30.41M

2024Q3

330

33.06M

34.86%

-33.72M

2024Q2

326

40.98M

43.17%

-33.17M

2024Q1

316

48.96M

52.78%

-20.37M

2023Q4

308

49.49M

53.68%

-10.26M

2023Q3

295

49.25M

53.86%

+8.83M

2023Q2

258

36.71M

65.25%

+1.46M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

Nantahala Capital Management, LLC

8.81M

9.15%

+370.31K

+4.39%

Jun 30, 2025

The Vanguard Group, Inc.

4.38M

4.56%

--

Jun 30, 2025

Renaissance Technologies LLC

2.82M

2.93%

+117.69K

+4.35%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

1.37M

1.43%

-11.56K

-0.83%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.02M

1.06%

-86.31K

-7.79%

Jun 30, 2025

Two Sigma Investments, LP

867.90K

0.9%

-357.19K

-29.16%

Jun 30, 2025

CM Management, LLC

724.38K

0.75%

+249.38K

+52.50%

Jun 30, 2025

Millennium Management LLC

694.52K

0.72%

-90.05K

-11.48%

Jun 30, 2025

Polen Capital Management, LLC

651.61K

0.68%

-129.46K

-16.57%

Sep 30, 2024

Peisert (Daniel A)

607.46K

0.63%

--

Mar 13, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

日付

種類

比率

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

May 17, 2021

Merger

4→1

詳細情報 Assertio Holdings Inc 企業名

Assertio Holdings Incの企業情報

Assertio Holdings Incの経営陣

収益内訳

株主

機関投資家保有株

株主動向

関連ETF

配当金

株式分割